Literature DB >> 24502536

Refractory celiac disease.

Georgia Malamut1, Christophe Cellier.   

Abstract

A small subset of celiac disease (CD) patients becomes refractory to a gluten-free diet with persistent malabsorption and intestinal villous atrophy. Diagnosis of this condition defined as refractory celiac disease (RCD) is made after exclusion of other small bowel diseases with villous atrophy. RCD has been subdivided into two subgroups according to the normal or abnormal phenotype of intraepithelial lymphocytes. Whereas normal RCD is hardly distinguishable from active CD, abnormal RCD has a severe clinical presentation and a very poor prognosis. We precisely describe below the different types of RCD and propose diagnostic and therapeutic guidelines for its clinical management.

Entities:  

Mesh:

Year:  2014        PMID: 24502536     DOI: 10.1586/17474124.2014.887438

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  4 in total

1.  Salivary proline-rich proteins and gluten: Do structural similarities suggest a role in celiac disease?

Authors:  Na Tian; Irene Messana; Daniel A Leffler; Ciaran P Kelly; Joshua Hansen; Tiziana Cabras; Alfredo D'Alessandro; Detlef Schuppan; Massimo Castagnola; Eva J Helmerhorst
Journal:  Proteomics Clin Appl       Date:  2015-04-24       Impact factor: 3.494

Review 2.  Advances in diagnosis and management of celiac disease.

Authors:  Ciarán P Kelly; Julio C Bai; Edwin Liu; Daniel A Leffler
Journal:  Gastroenterology       Date:  2015-02-03       Impact factor: 22.682

3.  Celiac Disease Treatment: Is It the Chicken or the Egg Yolk?

Authors:  Valentina Discepolo; Stefano Guandalini
Journal:  Dig Dis Sci       Date:  2017-05       Impact factor: 3.199

4.  A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease.

Authors:  Barbara Hrdlickova; Chris J Mulder; Georgia Malamut; Bertrand Meresse; Mathieu Platteel; Yoichiro Kamatani; Isis Ricaño-Ponce; Roy L J van Wanrooij; Maria M Zorro; Marc Jan Bonder; Javier Gutierrez-Achury; Christophe Cellier; Alexandra Zhernakova; Petula Nijeboer; Pilar Galan; Sebo Withoff; Mark Lathrop; Gerd Bouma; Ramnik J Xavier; Bana Jabri; Nadine C Bensussan; Cisca Wijmenga; Vinod Kumar
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-08       Impact factor: 2.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.